Skin Melanoma
📧 Sign up to get email alerts when something new happens for Skin Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma [Phase 3]
Phase 3 trial comparing RPH-075 to Keytruda in unresectable or metastatic skin melanoma is ongoing with undisclosed status.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma [Phase 2]
Phase II trial evaluating stereotactic body radiotherapy followed by ipilimumab in stage IV melanoma was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Study With T-cel Receptor Gene Therapy in Metastatic Melanoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a T-cell receptor gene therapy for metastatic melanoma, including stage IV skin melanoma and ocular me…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating RO4929097 (gamma-secretase/Notch pathway inhibitor) with cisplatin, vinblastine, and temozolomide in recurrent or…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.